VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,725,208 | -45.4% | 426,764 | -20.1% | 0.00% | -33.3% |
| Q2 2023 | $8,657,865 | -2.7% | 534,332 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,900,842 | +111467.3% | 534,332 | -37.0% | 0.00% | +50.0% |
| Q4 2022 | $7,978 | -99.7% | 848,727 | -7.1% | 0.00% | +100.0% |
| Q3 2022 | $2,486,000 | -33.0% | 913,963 | -28.8% | 0.00% | 0.0% |
| Q2 2022 | $3,710,000 | -10.1% | 1,283,925 | -6.7% | 0.00% | 0.0% |
| Q1 2022 | $4,126,000 | -15.6% | 1,375,485 | +29.4% | 0.00% | 0.0% |
| Q4 2021 | $4,890,000 | +1.6% | 1,063,108 | +38.7% | 0.00% | -50.0% |
| Q3 2021 | $4,815,000 | +139.3% | 766,723 | +128.3% | 0.00% | +100.0% |
| Q2 2021 | $2,012,000 | +1.8% | 335,878 | +7.5% | 0.00% | 0.0% |
| Q1 2021 | $1,976,000 | +76.9% | 312,404 | +57.5% | 0.00% | – |
| Q4 2020 | $1,117,000 | -4.0% | 198,359 | -0.7% | 0.00% | – |
| Q3 2020 | $1,163,000 | -16.1% | 199,825 | +3.9% | 0.00% | -100.0% |
| Q2 2020 | $1,387,000 | +243.3% | 192,373 | +122.8% | 0.00% | – |
| Q1 2020 | $404,000 | +28.3% | 86,327 | +119.6% | 0.00% | – |
| Q4 2019 | $315,000 | -82.1% | 39,306 | -81.5% | 0.00% | -100.0% |
| Q2 2019 | $1,760,000 | -16.5% | 212,048 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,108,000 | +42.6% | 212,048 | +9.7% | 0.00% | 0.0% |
| Q4 2018 | $1,478,000 | – | 193,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |